Media Pack
News

Current Edition

Volume 16 issue 2

Current Features

Volume 16 Issue 2

PCI Discusses Annex 1 Complaint Expansion Plans for Sterile Fill-Finish and Lyophilization 

In 2022 PCI Announced a $100 Million Investment into Expanding Its Sterile Fill-Finish Service Offering – Can You Provide an Update on How This is Progressing?    ...
8 July 2024 Volume 16 Issue 2 | Current Features
Continue Reading →
Volume 16 Issue 2

AI & Automation: How Advanced is Adoption in Life Sciences R&D?  

Forward-thinking life sciences organisations have switched on to the benefits of AI-powered automation, to transform their research and development operations and st...
8 July 2024 Volume 16 Issue 2 | Current Features Artificial Intelligence | blockchain
Continue Reading →
Volume 16 Issue 2

Alleviating Regulatory Burden Through Access Consortium 

While regulatory authorities are in- creasingly adopting reliance programs to assess applications, few offer the opportunity to take advantage of simultaneous assess...
8 July 2024 Volume 16 Issue 2 | Current Features COVID-19 | healthcare
Continue Reading →
Volume 16 Issue 2

Integrating Medical Devices into Pharmacovigilance Portfolios   

How to Navigate the Latest EU Medical Device Regulatory Landscape to Successfully Adapt your Pharma Portfolio Understanding medical device regulations is essentia...
8 July 2024 Volume 16 Issue 2 | Current Features development | drug
Continue Reading →
Volume 16 Issue 2

The Oncology Crux – Asking the Smart Oncology Questions Before Shaping an Asset’s Journey to Market   

With over 2,000 oncology clinical trials currently ongoing, the speed at which the market is evolving makes it increasingly difficult for pharmaceutical companies to...
8 July 2024 Volume 16 Issue 2 | Current Features
Continue Reading →
Volume 16 Issue 2

Engaging Minority Communities: Collaborative Practises and Long-Term Success  

The quest to understand and treat rare diseases poses unique challenges. Rare diseases, often referred to as orphan diseases, affect a small percentage of the popula...
8 July 2024 Volume 16 Issue 2 | Current Features development | healthcare
Continue Reading →

Advertisement

Current Edition

Volume 16 issue 2
 
 
 
 
 
 
Volume 16 Issue 2

PCI Discusses Annex 1 Complaint Expansion Plans for Sterile Fill-Finish and Lyophilization 

In 2022 PCI Announced a $100 Million Investment into Expanding Its Sterile Fill-Finish Service Offering – Can You Provide an Update on How This is Progressing?    ...
8 July 2024 Volume 16 Issue 2 | Current Features
Continue Reading →
Volume 16 Issue 2

AI & Automation: How Advanced is Adoption in Life Sciences R&D?  

Forward-thinking life sciences organisations have switched on to the benefits of AI-powered automation, to transform their research and development operations and st...
8 July 2024 Volume 16 Issue 2 | Current Features Artificial Intelligence | blockchain
Continue Reading →
Volume 16 Issue 2

Alleviating Regulatory Burden Through Access Consortium 

While regulatory authorities are in- creasingly adopting reliance programs to assess applications, few offer the opportunity to take advantage of simultaneous assess...
8 July 2024 Volume 16 Issue 2 | Current Features COVID-19 | healthcare
Continue Reading →
Volume 16 Issue 2

Integrating Medical Devices into Pharmacovigilance Portfolios   

How to Navigate the Latest EU Medical Device Regulatory Landscape to Successfully Adapt your Pharma Portfolio Understanding medical device regulations is essentia...
8 July 2024 Volume 16 Issue 2 | Current Features development | drug
Continue Reading →
Volume 16 Issue 2

The Oncology Crux – Asking the Smart Oncology Questions Before Shaping an Asset’s Journey to Market   

With over 2,000 oncology clinical trials currently ongoing, the speed at which the market is evolving makes it increasingly difficult for pharmaceutical companies to...
8 July 2024 Volume 16 Issue 2 | Current Features
Continue Reading →
Volume 16 Issue 2

Engaging Minority Communities: Collaborative Practises and Long-Term Success  

The quest to understand and treat rare diseases poses unique challenges. Rare diseases, often referred to as orphan diseases, affect a small percentage of the popula...
8 July 2024 Volume 16 Issue 2 | Current Features development | healthcare
Continue Reading →
 
 

Company Profiles

Woolcool
Company profile

Woolcool

Insulated packaging pioneers Woolcool® was launched in 2008 and offers superior insulated packaging for the transportation of temperature-sensitive goods using th...
26 March 2024 Company profile | T-Z
Continue Reading →
KAHLE
E-M

KAHLE

If you’re looking for an automation partner who understands the precision and care required to manufacture the world’s finest drug delivery devices, consider Kahle A...
11 March 2024 E-M | Company profile
Continue Reading →
BIOPHARMA GROUP
Company profile

BIOPHARMA GROUP

Biopharma Group: A Trusted Partner for Freeze-Drying and Beyond Biopharma Group is a leading contract development and manufacturing organization (CDMO) with a wel...
6 March 2024 Company profile | A-D
Continue Reading →
Orifarm
Company profile

Orifarm

At Orifarm Clinical Trial Supplies, we understand that each patient is a real person beyond a number on a spreadsheet, which helps our team to focus on high quality ...
21 February 2024 Company profile | N-S
Continue Reading →
BENEO offers versatile filler-binder excipient with exceptional taste properties
Company profile

BENEO offers versatile filler-binder excipient with exceptional taste properties

BENEO is part of the Südzucker Group and a member of the International Pharmaceutical Excipients Council (IPEC). The company produces galenIQ™ (Isomalt Ph. Eur.,...
10 November 2023 Company profile | A-D
Continue Reading →
Stoelzle Pharma
Company profile

Stoelzle Pharma

Stoelzle Glass Group stands as a premier manufacturer of high-quality primary packaging glass designed for pharmaceutical and healthcare products. Our extensive prod...
10 October 2023 Company profile | N-S
Continue Reading →
logo-ipi-w.png

International Pharmaceutical Industry

IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative

Facebook Linkedin Tumblr
IPI Media © 2024, All Rights Reserved – Powered by Teksyte